Transcription factor binding sites downstream of the human immunodeficiency virus type 1 transcription start site are important for virus infectivity

Journal of Virology

Volumn 71, Issue 8, 1997, Pages 6113-6127

  Van Lint, Carine ^a   Amella, Carol Ann ^a   Emiliani, Stephane ^a   John, Malcolm ^a   Jie, Tun ^a   Verdin, Eric ^a  

^a PICOWER INST FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR SP1;

ARTICLE; BINDING SITE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; VIRUS CELL INTERACTION; VIRUS INFECTIVITY; VIRUS MUTANT; VIRUS TRANSCRIPTION;

EID: 0030788299     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.8.6113-6127.1997     Document Type: Article

References (84)

1. Abdollahi, A., K. A. Lord, B. Hoffman-Liebermann, and D. A. Liebermann. 1991. Interferon regulatory factor 1 is a myeloid differentiation primary response gene induced by interleukin-6 and leukemia inhibitory factor: role in growth inhibition. Cell Growth Differ. 2:401-407.
2. Adachi, A., H. E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M. A. Martin. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284-291.
3. Aldovini, A., and B. Walker. 1990. Techniques in HIV research. Stockton Press, New York, N.Y.
4. Angel, P., M. Imagawa, R. Chiu, B. Stein, R. J. Imbra, H. J. Rahmsdorf, C. Jonat, P. Herrlich, and M. Karin. 1987. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49:729-739.
5. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. A. Smith, J. G. Seidman, and K. Strahl (ed.). 1993. Current protocols in molecular biology. Greene Publishing Associates and Wiley Interscience, New York, N.Y.
6. Baudin, F., R. Marquet, C. Isel, J. L. Darlix, B. Ehresmann, and C. Ehresmann. 1993. Functional sites in the 5′ region of human immunodeficiency virus type 1 RNA form defined structural domains. J. Mol. Biol. 229:382-397.
7. Benbrook, D. M., and N. C. Jones. 1990. Heterodimer formation between CREB and JUN proteins. Oncogene 5:295-302.
8. Boise, L. H., B. Petryniak, X. Mao, C. H, June, C.-Y. Wang, T. Lindsten, R. Bravo, K. Kovary, J. M. Leiden, and C. B. Thompson. 1993. The NFAT-1 binding complex in activated T cells contains Fra-1 and JunB. Mol. Cell. Biol. 13:1911-1919.
9. Bovolenta, C., J. Lou, Y. Kanno, B.-K. Park, A. Thornton, J. E. Coligan, M. Schubert, and K. Ozato. 1995. Vesicular stomatitis virus infection induces a nuclear DNA-binding factor specific for the interferon-stimulated response element. J. Virol. 69:4173-4181.
10. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
11. Cullen, B. R. 1991. Regulation of HIV-1 gene expression. FASEB J. 5:2361-2368.
12. El Kharroubi, A., and M. A. Martin. 1996. cis-acting sequences located downstream of the human immunodeficiency virus type 1 promoter affect its chromatin structure and transcriptional activity. Mol. Cell. Biol. 16:2958-2966.
13. El Kharroubi, A., and E. Verdin. 1994. Protein-DNA interactions within DNase I-hypersensitive sites located downstream of the HIV-1 promoter. J. Biol. Chem. 269:19916-19924.
14. Faisst, S., and S. Meyer. 1992. Compilation of vertebrate-encoded transcription factors. Nucleic Acids Res. 20:3-26.
15. Franza, B. R. J., F. J. Rauscher, S. F. Josephs, and T. Curran. 1988. The fos complex and fos-related antigens recognize sequence elements that contain AP1 binding sites. Science 239:1150-1153.
16. Fraser, J. D., B. A. Irving, G. R. Crabtree, and A. Weiss. 1991. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science 251:313-316.
17. Fromental, C., M. Kanno, H. Nomiyama, and P. Chambon. 1988. Cooperativity and hierarchical levels of functional organization in the SV40 enhancer. Cell 54:943-953.
18. Fujita, T., L. F. Reis, N. Watanabe, Y. Kimura, T. Taniguchi, and J. Vilcek. 1989. Induction of the transcription factor IRF-1 and interferon-β mRNAs by cytokines and activators of second-messenger pathways. Proc. Natl. Acad. Sci. USA 86:9936-9940.
19. Gabuzda, D. H., J. L. Hess, J. A. Small, and J. E. Clements. 1989. Regulation of the visna virus long terminal repeat in macrophages involves cellular factors that bind sequences containing AP-1 sites. Mol. Cell. Biol. 9:2728-2733.
20. Gaynor, R. 1992. Cellular transcription factors involved in the regulation of HIV-1 gene expression. AIDS 6:347-363.
21. Gaynor, R. B. 1995. Regulation of HIV-1 gene expression by the transactivator protein Tat. Curr. Top. Microbiol. Immunol. 193:51-77.
22. Hai, T., and T. Curran. 1991. Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc. Natl. Acad. Sci. USA 88:3720-3724.
23. Haines, D. S., and D. H. Gillespie. 1992. RNA abundance measured by a lysate RNase protection assay. Bio Techniques 12:736-741.
24. Harada, H., T. Fujita, M. Miyamoto, Y. Kimura, M. Maruyama, A. Furia, T. Miyata, and T. Taniguchi. 1989. Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 58:729-739.
25. Harrich, D., C. Hsu, E. Race, and R. B. Gaynor. 1994. Differential growth kinetics are exhibited by human immunodeficiency virus type 1 TAR mutants. J. Virol. 68:5899-5910.
26. Harrich, D., C. Ulich, and R. B. Gaynor. 1996. A critical role for the TAR element in promoting efficient human immunodeficiency virus type 1 reverse transcription. J. Virol. 70:4017-4027.
27. Harrison, G. P., and A. M. Lever. 1992. The human immunodeficiency virus type 1 packaging signal and major splice donor region have a conserved stable secondary structure. J. Virol. 66:4144-4153.
28. Herr, W., and J. Clarke. 1986. The SV40 enhancer is composed of multiple functional elements that can compensate for one another. Cell 45:461-470.
29. Hess, J. L., J. A. Small, and J. E. Clements. 1989. Sequences in the visna virus long terminal repeat that control transcriptional activity and respond to viral trans-activation: involvement of AP-1 sites in basal activity and trans-activation. J. Virol. 63:3001-3015.
30. Ho, A. M., J. Jain, A. Rao, and P. G. Hogan. 1994. Expression of the transcription factor NFATp in a neuronal cell line and in the murine nervous system. J. Biol. Chem. 269:28181-28186.
31. Ho, S. N., D. J. Thomas, L. A. Timmerman, X. Li, U. Francke, and G. R. Crabtree. 1995. NFATc3, a lymphoid-specific NFATc family member that is calcium-regulated and exhibits distinct DNA binding specificity. J. Biol. Chem. 270:19898-19907.
32. Hoey, T., Y.-L. Sun, K. Williamson, and X. Xu. 1995, Isolation of two new members of the NF-AT gene family and functional characterization of the NF-AT proteins. Immunity 2:461-472.
33. Ihle, J. N., B. A. Witthuhn, F. W. Quelle, K. Yamamoto, and O. Silvennoinen. 1995. Signaling through the hematopoietic cytokine receptors. Annu. Rev. Immunol. 13:369-398.
34. Jain, J., E. Burgeon, T. M. Badalian, P.G. Hogan, and A. Rao. 1995. A similar DNA-binding motif in NFAT family proteins and the rel homology region. J. Biol. Chem. 270:4138-4145.
35. James, C. D., J. He, P. Collins, M. J. Allalunis-Turner, and R. S. Day. 1993. Localization of chromosome 9p homozygous deletions in glioma cell lines with markers constituting a continuous linkage group. Cancer Res. 53:3674-3676.
36. Jeang, K.-T., R. Chiu, E. Santos, and S.-J. Kim. 1991. Induction of the HTLV-1 LTR by Jun occurs through the Tax-responsive 21-bp elements. Virology 181:218-227.
37. Jones, K., J. Kadonaga, P. Luciw, and R. Tjian. 1986. Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1. Science 232: 755-759.
38. Jones, K. A. 1993. Tat and the HIV-1 promoter. Curr. Opin. Cell Biol. 5:461-468.
39. Jones, K. A., and B. M. Peterlin. 1994. Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem. 63:717-743.
40. Kang, S. M., J. K. Wakefield, and C. D. Morrow. 1996. Mutations in both the U5 region and the primer-binding site influence the selection of the tRNA used for the initiation of HIV-1 reverse transcription. Virology 222:401-414.
41. Karin, M. 1991. The API complex and its role in transcriptional control by protein kinase C, p. 235-253. In P. Cohen and J. G. Foulkes (ed.), The hormonal control regulation of gene transcription. Elsevier Science, Amsterdam, The Netherlands.
42. Kim, J. Y. H., F. Gonzalez-Scarano, S. L. Zeichner, and J. C. Alwine. 1993. Replication of type 1 human immunodeficiency viruses containing linker substitution mutations in the -201 to -130 region of the long terminal repeat. J. Virol. 67:1658-1662.
43. Laspia, M. F., P. Wendel, and M. B. Mathews. 1993. HIV-1 Tat overcomes inefficient transcriptional elongation in vitro. J. Mol. Biol. 232:732-746.
44. Leonard, J., C. Parrott, A. J. Buckler-White, W. Turner, E. K. Ross, M. A. Martin, and A. B. Rabson. 1989. The NF-κ B binding sites in the human immunodeficiency virus type 1 long terminal repeat are not required for virus infectivity. J. Virol. 63:4919-4924.
45. Levy, D. E., D. S. Kessler, R. Pine, N. Reich, and J. E. Darnell. 1988. Interferon-induced nuclear factors that bind a shared promoter element correlate with positive and negative transcriptional control. Genes Dev. 2:383-393.
46. Loh, T. P., L. L. Sievert, and R. W. Scott. 1988. Negative regulation of retrovirus expression in embryonal carcinoma cells mediated by an intragenic domain. J. Virol. 62:4086-4095.
47. Loh, T. P., L. L. Sievert, and R. W. Scott. 1994. Proviral sequences that restrict retroviral expression in mouse embryonal carcinoma cells. Mol. Cell. Biol. 7:3775-3784.
48. Lu, Y., M. Stenzel, J. Sodroski, and W. Haseltine. 1989. Effects of long terminal repeat mutations on human immunodeficiency virus type 1 replication. J. Virol. 63:4115-4119.
49. Luo, C., E. Burgeon, and A. Rao. 1996. Mechanisms of transactivation by nuclear factor of activated T cells. J. Exp. Med. 184:141-147.
50. Mastrangelo, I., A. Courey, J. Wall, S. Jackson, and P. Hough. 1991. cDNA looping and Sp1 multimer links: a mechanism for transcriptional synergism and enhancement. Proc. Natl. Acad. Sci. USA 88:5670-5674.
51. Masuda, E. S., Y. Naito, H. Tokumitsu, D. Campbell, F. Saito, C. Hannum, K.-I. Arai, and N. Arai. 1995. NFATx, a novel member of the nuclear factor of activated T cells family that is expressed predominantly in the thymus. Mol. Cell. Biol. 15:2697-2706.
52. Maurer, B., E. Serfling, V. Ter Meulen, and A. Rehwilm. 1991. Transcription factor AP1 modulates the activity of the human foamy virus long terminal repeat. J. Virol. 65:6553-6557.
53. McCaffrey, P. G., C. Luo, T. K. Kerppola, J. Jain, T. M. Badalian, A. M. Ho, E. Burgeon, W. S. Lane, J. N. Lambert, T. Curran, G. L. Verdine, A. Rao, and P. G. Hogan. 1993. Isolation of the cyclosporin-sensitive T cell transcription factor NFATp. Science 262:750-754.
54. Mercurio, F., and M. Karin. 1989. Transcription factors AP-3 and AP-2 interact with the SV40 enhancer in a mutually exclusive manner. EMBO J. 1455-1460.
55. Mitchell, P. J., C. Wang, and R. Tjian. 1987. Positive and negative regulation of transcription in vitro: enhancer-binding protein AP-2 is inhibited by SV40 T antigen. Cell 50:847-861.
56. Miyamoto, M., T. Fujita, Y. Kimura, M. Maruyama, H. Harada, Y. Sudo, T. Miyata, and T. Taniguchi. 1988. Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-β gene regulatory elements. Cell 54:903-913.
57. Ondek, B., L. Gloss, and W. Herr. 1988. The SV40 enhancer contains two distinct levels of organization. Nature 333:40-45.
58. Osborn, L., S. Kunkel, and G. Nabel. 1989. Tumor necrosis factor-alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor-kappa B. Proc. Natl. Acad. Sci. USA 86:2336-2340.
59. Ott, M., S. Emiliani, C. Van Lint, G. Herbein, J. Lovett, N. Chirmule, T. McCloskey, S. Pahwa, and E. Verdin. 1997. Immune hyperactivation of HIV-1 infected T cells mediated by Tat and the CD28 pathway. Science 275:1481-1485.
60. Pazin, M. J., P. L. Sheridan, K. Cannon, Z. Cao, J. G. Keck, J. T. Kadonaga, and K. A. Jones. 1996. NF-kappa B-mediated chromatin reconfiguration and transcriptional activation of the HIV-1 enhancer in vitro. Genes Dev. 10:37-49.
61. Rasmussen, J. A., and E. Gilboa. 1987. Significance of DNase-1 hypersensitive sites in the long terminal repeats of a Moloney murine leukemia virus vector. J. Virol. 61:1368-1374.
62. Risse, G., K. Joos, M. Neuberg, H.-J. Bruller, and R. Muller. 1989. Asymmetrical recognition of the palindromic AP-1 binding site (TRE) by Fos protein complexes. EMBO J. 8:3825-3832.
63. Roebuck, K. A., D. A. Brenner, and M. F. Kagnoff. 1993. Identification of c-fos-responsive elements downstream of TAR in the long terminal repeat of human immunodeficiency virus type-1. J. Clin. Invest. 92:1336-1348.
64. Ross, E. K., A. J. Buckler-White, A. B. Rabson, G. Englund, and M. A. Martin. 1991. Contribution of NF-κB and Sp1 binding motifs to the replicative capacity of human immunodeficiency virus type 1: distinct patterns of viral growth are determined by T-cell types. J. Virol. 65:4350-4358.
65. Ryseck, R. P., and R. Bravo. 1991. c-jun, junB and junD differ in their binding affinities to AP-1 and CRE consensus sequences: effect of Fos proteins. Oncogene 6:533-542.
66. Sakuragi, J.-I., and A. T. Panganiban. 1997. Human immunodeficiency virus type 1 RNA outside the primary encapsidation and dimer linkage region affects RNA dimer stability in vivo. J. Virol. 71:3250-3254.
67. Schindler, C., and J. E. Darnell. 1995. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu. Rev. Biochem. 64:621-651.
68. Sen, R., and D. Baltimore. 1986. Inducibility of K immunoglobulin enhancer-binding protein NF-kB by a posttranscriptional mechanism. Cell 47:921-928.
69. Shaw, J. P., P. J. Utz, D. B. Durand, J. J. Toole, E. A. Emmel, and G. R. Crabtree. 1988. Identification of a putative regulator of early T cell activation genes. Science 241:202-205.
70. Sheridan, P. L., C. T. Sheline, K. Cannon, M. L. Voz, M. J. Pazin, J. T. Kadonaga, and K. A. Jones. 1995. Activation of the HIV-1 enhancer by the LEF-1 HMG protein on nucleosome-assembled DNA in vitro. Genes Dev. 9:2090-2104.
71. Shirakawa, F., K. Saito, C. A. Bonagura, D. L. Galson, M. J. Fenton, A. C. Webb, and P. E. Auron. 1993. The human prointerleukin-1β gene requires DNA sequences both proximal and distal to the transcription start site for tissue-specific induction. Mol. Cell. Biol. 13:1322-1344.
72. Simpson, R. T., S. Y. Roth, R. H. Morse, H. G. Patterton, J. P. Cooper, M. Murphy, M. P. Kladde, and M. Shimizu. 1993. Nucleosome positioning and transcription. Cold Spring Harbor Symp. Quant. Biol. 58:237-245.
73. Smeal, T., P. Angel, J. Meek, and M. Karin. 1989. Different requirements for the formation of Jun:Jun and Jun:Fos complexes. Genes Dev. 3:2091-2100.
74. Sparger, E. E., B. L. Shacklett, L. Renshaw-Gegg, P. A. Barry, N. C. Pedersen, J. H. Elder, and P. A. Luciw. 1992. Regulation of gene expression directed by the long terminal repeat of the feline immunodeficiency virus. Virology 187:165-177.
75. Su, W., S. Jackson, R. Tjian, and H. Echols. 1991. DNA looping between sites for transcriptional activation: self-association of DNA-bound Sp1. Genes Dev. 5:820-826.
76. Thornton, A. M., R. M. L. Buller, A. L. DeVico, I. Ming-Wang, and K. Ozato. 1996. Inhibition of human immunodeficiency virus type 1 and vaccinia virus infection by a dominant negative factor of the interferon regulatory factor family expressed in monocytic cells. Proc. Natl. Acad. Sci. USA 93:383-387.
77. Tsukiyama, T., O. Niwa, and K. Yokoro. 1990. Characterization of the negative regulatory element of the 5′ noncoding region of Moloney murine leukemia in mouse embryonal carcinoma cells. Virology 177:772-776.
78. Van Lint, C., S. Emiliani, M. Ott, and E. Verdin. 1996. Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. EMBO J. 15:1112-1120.
79. Van Lint, C., J. Ghysdael, P. Paras, Jr., A. Burny, and E. Verdin. 1994. A transcriptional regulatory element is associated with a nuclease-hypersensitive site in the pol gene of human immunodeficiency virus type 1. J. Virol. 68:2632-2648.
80. Verdin, E. 1991. DNase I-hypersensitive sites are associated with both long terminal repeats and with the intragenic enhancer of integrated human immunodeficiency virus type 1. J. Virol. 65:6790-6799.
81. Verdin, E., P. Paras, Jr., and C. Van Lint. 1993. Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation. EMBO J. 12:3249-3259.
82. Zeichner, S. L., J. Y. Kim, and J. C. Alwine. 1991. Linker-scanning mutational analysis of the transcriptional activity of the human immunodeficiency virus type 1 long terminal repeat. J. Virol. 65:2436-2444.
83. Zenke, M., T. Grundstrom, H. Matthes, M. Wintzerith, C. Schatz, A. Wildeman, and P. Chambon. 1986. Multiple sequence motifs are involved in SV40 enhancer function. EMBO J. 5:387-397.
84. Zerial, M., L. Tosehi, R. P. Ryseck, M. Schuermann, R. Muller, and R. Bravo. 1989. The product of a novel growth factor activated gene, fosB, interacts with JUN proteins enhancing their DNA binding activity. EMBO J. 8:805-813.